✦ LIBER ✦

Kidney cancer: Bisphosphonates in the era of antiangiogenic targeted therapy

✍ Scribed by Roos, Frederik C.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1794 OUTCOMES WITH NEPHRECTOMY FOR METAS

✍ Williams, Steve; Hakimi, A. Ari; Ghavamian, Reza; Rabbani, Farhang 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 101 KB

Experimental study of antiangiogenic gen

✍ Yasuo Okada; Hikaru Ueno; Masataka Katagiri; Takahiro Oneyama; Kana Shimomura; S 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 552 KB

Collateral damage: toxic effects of targ

✍ Rebecca L Stone; Anil K Sood; Robert L Coleman 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 220 KB

231 Efficacy of VEGFR2 targeted mAb ther

✍ D. Surguladze; M.J. Plym; J. Malaby; M. Prewett; M. Rutstein; J. Schwartz; D. Lu 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Toxicities of Targeted Therapy and Their

✍ Giuseppe Di Lorenzo; Camillo Porta; Joaquim Bellmunt; Cora Sternberg; Ziya Kirka 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 433 KB

Bone Disease in Breast Cancer: The Era o

✍ Larissa A. Korde; Julie R. Gralow 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 146 KB